Halozyme Therapeutics shares owned by NorthCrest Asset Manangement
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by NorthCrest Asset Manangement
from 13F filings
Historical chart of NorthCrest Asset Manangement investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by NorthCrest Asset Manangement consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by NorthCrest Asset Manangement
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.6M | 30k | 52.36 |
| 2024-03-31 | $1.2M | 30k | 40.68 |
| 2023-12-31 | $1.4M | 37k | 36.96 |
| 2023-09-30 | $1.4M | 37k | 38.20 |
| 2023-06-30 | $1.3M | 37k | 36.07 |
| 2023-03-31 | $1.4M | 37k | 38.19 |
| 2022-12-31 | $1.3M | 24k | 56.91 |
| 2022-09-30 | $929k | 24k | 39.53 |
| 2022-06-30 | $1.0M | 24k | 44.00 |
| 2022-03-31 | $937k | 24k | 39.87 |
| 2021-12-31 | $422k | 11k | 40.19 |
More positions owned by NorthCrest Asset Manangement
View all positions for NorthCrest Asset Manangement